V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280004320 | 280003042 | null | 89 | Adjuvant (A) | 2016-08-25 | 2016-09-06 | EOX | N | Y | 280027134 | EOX |
| 280004321 | 280003042 | null | 50.55 | Palliative (P) | 2015-07-15 | 2015-07-16 | Cisplatin+Gemcitabine (gallbladder) | N | Y | 280027134 | CISPLATIN + GEMCITABINE |
| 280004322 | 280003042 | 1.8 | 116.8 | Curative (C) | 2017-05-16 | 2017-05-17 | Cisplatin + Gemcitabine (D 1 & 8) | N | Y | 280027134 | CISPLATIN + GEMCITABINE |
| 280004323 | 280003043 | 1.83 | 15.8 | Curative (C) | null | 2016-01-14 | Carboplatin AUC 6 - 10 | Y | null | 280027137 | CARBOPLATIN |
| 280004324 | 280007526 | null | 72.2 | Palliative (P) | 2017-07-13 | 2017-07-19 | CETUXIMAB | 2 | N | 280027139 | CETUXIMAB |
| 280004325 | 280007526 | 1.8 | 90.3 | Curative (C) | 2013-08-27 | 2013-08-30 | EW EuroEwing 2012 Arm B VDC | 02 | N | 280027139 | TRIAL |
| 280004326 | 280003044 | 1.49 | 92.1 | Curative (C) | 2015-12-10 | 2015-12-15 | CISPLATIN + GEMCITABINE | null | N | 280027144 | CISPLATIN + GEMCITABINE |
| 280004327 | 280007527 | 1.85 | 109 | Curative (C) | 2013-07-29 | 2013-08-06 | CETUXIMAB | 1 | Y | 280027145 | CETUXIMAB |
| 280004328 | 280003045 | 1.7 | 82.2 | Curative (C) | null | 2016-11-01 | Carboplatin AUC 2 - 5 | N | N | 280027146 | CARBOPLATIN |
| 280004329 | 280007528 | 1.59 | 71.2 | Neo-adjuvant (N) | 2012-10-31 | 2012-11-01 | NB HRNBL-1 COJEC Ind COURSE A | null | N | 280027147 | NOT MATCHED |
| 280004330 | 280007528 | 1.6 | 53 | Curative (C) | 2017-04-13 | 2017-04-13 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | Y | 280027147 | CISPLATIN + GEMCITABINE |
| 280004331 | 280003046 | 1.84 | 109 | Curative (C) | 2016-03-08 | 2016-03-08 | Carboplatin + Etoposide iv&po | Y | N | 280027151 | CARBOPLATIN + ETOPOSIDE |
| 280004332 | 280007529 | null | null | Curative (C) | null | 2017-03-28 | STS Rhabdomyosarcoma RMS 2005 IVAVV | Y | null | 280027152 | NOT MATCHED |
| 280004333 | 280007529 | 1.77 | 76 | Curative (C) | 2016-12-05 | 2016-12-18 | Carboplatin AUC 6 - 10 | 2 | null | 280027152 | CARBOPLATIN |
| 280004334 | 280007529 | 1.7 | 67.2 | Curative (C) | 2016-09-18 | 2016-09-18 | CARBOPLATIN + PACLITAXEL | 02 | null | 280027152 | CARBOPLATIN + PACLITAXEL |
| 280004335 | 280007529 | null | 69.9 | Palliative (P) | 2017-05-11 | 2017-05-11 | EW EuroEwing 2012 Arm B VDC | N | N | 280027152 | TRIAL |
| 280004336 | 280007529 | 1.81 | 64.6 | Curative (C) | 2016-05-26 | 2016-05-26 | EOX | N | N | 280027152 | EOX |
| 280004337 | 280003047 | 1.74 | 67.5 | Curative (C) | 2017-09-10 | 2017-09-20 | Carboplatin + Paclitaxel (3 weekly) | N | Y | 280027157 | CARBOPLATIN + PACLITAXEL |
| 280004338 | 280003047 | 1.74 | 89.3 | Curative (C) | 2013-04-02 | 2013-04-07 | Cisplatin + Gemcitabine (D 1 & 8) | null | N | 280027157 | CISPLATIN + GEMCITABINE |
| 280004339 | 280003047 | 1.74 | 89.1 | Curative (C) | 2017-04-09 | 2017-04-16 | Carboplatin + Paclitaxel (3 weekly) | N | Y | 280027157 | CARBOPLATIN + PACLITAXEL |
| 280004340 | 280003047 | 0 | 92.3 | Curative (C) | 2016-05-13 | 2016-05-16 | Trial Unspecified | N | N | 280027157 | TRIAL |
| 280004341 | 280003047 | 1.67 | 65.2 | Curative (C) | 2018-01-15 | 2018-01-16 | CISPLATIN + GEMCITABINE | 02 | null | 280027157 | CISPLATIN + GEMCITABINE |
| 280004342 | 280003048 | 1.85 | 84.2 | Palliative (P) | 2017-04-13 | 2017-04-24 | EOX | N | N | 280027167 | EOX |
| 280004343 | 280003048 | 1.64 | 59 | Curative (C) | 2014-07-31 | 2014-08-26 | CARBOPLATIN | N | Y | 280027167 | CARBOPLATIN |
| 280004344 | 280003049 | 1.73 | 79.7 | Curative (C) | 2015-07-24 | 2015-07-24 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | Y | 280027170 | CISPLATIN + GEMCITABINE |
| 280004345 | 280003049 | null | null | Palliative (P) | 2016-02-22 | 2016-03-03 | Carboplatin AUC 6 - 10 | N | null | 280027170 | CARBOPLATIN |
| 280004346 | 280003049 | 1.6 | null | Curative (C) | 2015-07-04 | 2015-07-15 | Cetuximab 7 day (Cycle 1) | 02 | N | 280027170 | CETUXIMAB |
| 280004347 | 280003049 | 1.79 | 73.9 | null | 2013-10-02 | 2013-10-09 | Trial Unspecified | N | Y | 280027170 | TRIAL |
| 280004348 | 280003049 | 0 | 77.9 | Curative (C) | 2016-10-06 | 2016-10-08 | null | N | Y | 280027170 | NOT MATCHED |
| 280004349 | 280003050 | 1.66 | 65 | Curative (C) | 2017-11-02 | 2017-11-16 | CETUXIMAB | Y | Y | 280027182 | CETUXIMAB |
| 280004350 | 280003051 | 1.86 | 2.3 | Curative (C) | 2016-09-20 | 2016-09-26 | Trial Unspecified | Y | Y | 280027184 | TRIAL |
| 280004351 | 280007533 | 1.8 | null | Palliative (P) | 2016-05-18 | 2016-06-16 | Carboplatin AUC 2 - 5 | N | Y | 280027186 | CARBOPLATIN |
| 280004352 | 280007533 | 1.77 | 118 | Curative (C) | 2016-08-30 | 2016-09-06 | CARBOPLATIN + ETOPOSIDE | Y | N | 280027186 | CARBOPLATIN + ETOPOSIDE |
| 280004353 | 280007533 | null | 54.2 | Curative (C) | null | 2014-12-13 | Carboplatin AUC 6 - 10 | 01 | null | 280027186 | CARBOPLATIN |
| 280004354 | 280007533 | 1.7 | 95.8 | Palliative (P) | 2014-07-12 | 2014-07-23 | CARBOPLATIN + PACLITAXEL | N | Y | 280027186 | CARBOPLATIN + PACLITAXEL |
| 280004355 | 280011825 | 1.7 | 108 | Adjuvant (A) | 2015-08-05 | 2015-08-05 | CETUXIMAB | N | Y | 280027191 | CETUXIMAB |
| 280004356 | 280003052 | 1.57 | 70.4 | Neo-adjuvant (N) | 2016-08-29 | 2016-09-17 | CARBOPLATIN | N | Y | 280027194 | CARBOPLATIN |
| 280004357 | 280003052 | 1.74 | 90.3 | Curative (C) | 2017-05-25 | 2017-06-27 | CARBOPLATIN + PACLITAXEL | N | N | 280027194 | CARBOPLATIN + PACLITAXEL |
| 280004358 | 280003053 | null | 59 | Palliative (P) | 2013-05-08 | 2013-05-08 | Cisplatin + Gemcitabine (D 1 & 8) | N | Y | 280027196 | CISPLATIN + GEMCITABINE |
| 280004359 | 280003053 | 1.63 | 55 | null | 2016-01-15 | 2016-02-01 | Cetuximab 7 day (>Cycle 2) | N | N | 280027196 | CETUXIMAB |
| 280004360 | 280009840 | 1.87 | 98 | Curative (C) | 2014-09-25 | 2014-09-25 | Trial Unspecified | 02 | null | 280027201 | TRIAL |
| 280004361 | 280009840 | 1.6 | null | null | 2013-11-05 | 2013-11-29 | Cisplatin+Gemcitabine (gallbladder) | null | null | 280027201 | CISPLATIN + GEMCITABINE |
| 280004362 | 280009840 | 1.61 | 73 | Curative (C) | 2014-12-02 | 2014-12-03 | Cisplatin + Gemcitabine (D 1 & 8) | N | Y | 280027201 | CISPLATIN + GEMCITABINE |
| 280004363 | 280011826 | 1.77 | 70.1 | Neo-adjuvant (N) | 2016-04-17 | 2016-05-16 | CARBOPLATIN + RT | N | N | 280027204 | CARBOPLATIN + RT |
| 280004364 | 280011826 | null | 69.9 | Curative (C) | 2014-02-07 | 2015-04-29 | Olaratumab | Y | Y | 280027204 | NOT MATCHED |
| 280004365 | 280011826 | null | null | Palliative (P) | 2018-03-24 | 2018-03-24 | Cisplatin+Gemcitabine (gallbladder) | N | null | 280027204 | CISPLATIN + GEMCITABINE |
| 280004366 | 280012092 | 1.66 | 56.8 | Palliative (P) | 2017-08-20 | 2017-09-10 | Trial Unspecified | N | Y | 280027210 | TRIAL |
| 280004367 | 280012092 | 1.66 | 72.7 | Curative (C) | 2016-07-03 | 2016-08-17 | EOX | N | N | 280027210 | EOX |
| 280004368 | 280003054 | 1.78 | null | Palliative (P) | 2016-04-30 | 2016-05-05 | Cetuximab 7 day (Cycle 1) | 2 | N | 280027215 | CETUXIMAB |
| 280004369 | 280007536 | null | 74.1 | null | null | 2016-02-06 | Carboplatin + Etoposide IV 3 day | 2 | null | 280027217 | CARBOPLATIN + ETOPOSIDE |